Takeshi Kawamura
6PUBLICATIONS
34CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 17, 2025
Longitudinal antibody titers measured after COVID-19 mRNA vaccination can identify individuals at risk for subsequent infection.Hyeongki Park, Naotoshi Nakamura, Sho Miyamoto
|Nov 06, 2022
RNA-binding proteins of KHDRBS and IGF2BP families control the oncogenic activity of MLL-AF4.Hiroshi Okuda, Ryo Miyamoto, Satoshi Takahashi
|Jun 10, 2022
Factors associated with anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein antibody titer and neutralizing activity among healthcare workers following vaccination with the BNT162b2 vaccine.Yurie Kobashi, Yuzo Shimazu, Takeshi Kawamura
|May 05, 2022
The serological diversity of serum IgG/IgA/IgM against SARS-CoV-2 nucleoprotein, spike, and receptor-binding domain and neutralizing antibodies in patients with COVID-19 in Japan.Yudai Kaneko, Akira Sugiyama, Toshiya Tanaka
|Jan 27, 2021
PERK inhibition attenuates vascular remodeling in pulmonary arterial hypertension caused by BMPR2 mutation.Takashi Shimizu, Yoshiki Higashijima, Yasuharu Kanki
|Feb 15, 2018
Development of drug discovery screening system by molecular interaction kinetics-mass spectrometry.Naoko Obi, Tetsuya Fukuda, Noboru Nakayama
Pageof 1
Frequent Collaborators
2 joint publications
Yurie Kobashi
1 joint publications
Takashi Shimizu
1 joint publications
Yasuharu Kanki
1 joint publications
Yudai Kaneko
1 joint publications
Hiroshi Okuda
1 joint publications
Tomohiko Tamura
1 joint publications
Akihiko Yokoyama
1 joint publications
Hyeongki Park
1 joint publications
Naotoshi Nakamura
1 joint publications
Sho Miyamoto
